← Back to Search

Cash Benefits for Pregnancy

N/A
Waitlist Available
Led By Sumit D Agarwal, MD, MPH
Research Sponsored by Harvard Medical School (HMS and HSDM)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 20 months
Awards & highlights
No Placebo-Only Group

Summary

This trial studied how cash benefits impacted Chelsea, MA residents' reproductive and perinatal health in the first two years of the COVID pandemic.

Who is the study for?
This trial is for residents of Chelsea, Massachusetts with a household income at or below 30% of the HUD's Area Median Income and who are of childbearing age. It aims to understand how receiving extra cash might affect their reproductive and perinatal health.
What is being tested?
The study looks at the effects of receiving a cash benefit versus no cash benefit on reproductive/perinatal health during COVID-19. It uses data from the Chelsea Eats program which provided money through a lottery over ten months.
What are the potential side effects?
Since this trial involves financial benefits rather than medical treatments, there are no direct side effects like those associated with drugs or medical procedures.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~20 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 20 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Pregnancy
Secondary study objectives
Abortion
Composite of birth outcomes
Contraception
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Treatment GroupExperimental Treatment1 Intervention
Participants in the treatment group received up to $400 per month.
Group II: Control GroupActive Control1 Intervention
Participants in the control group did not receive monthly cash benefits.

Find a Location

Who is running the clinical trial?

Harvard Medical School (HMS and HSDM)Lead Sponsor
204 Previous Clinical Trials
1,313,070 Total Patients Enrolled
Brigham and Women's HospitalOTHER
1,670 Previous Clinical Trials
11,874,651 Total Patients Enrolled
Sumit D Agarwal, MD, MPHPrincipal InvestigatorBrigham and Women's Hospital and Harvard Medical School
~678 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top